Edition:
India

Rigel Pharmaceuticals Inc (RIGL.OQ)

RIGL.OQ on NASDAQ Stock Exchange Global Select Market

3.72USD
13 Dec 2017
Change (% chg)

$0.11 (+3.05%)
Prev Close
$3.61
Open
$3.63
Day's High
$3.81
Day's Low
$3.63
Volume
469,231
Avg. Vol
407,331
52-wk High
$4.47
52-wk Low
$1.94

Latest Key Developments (Source: Significant Developments)

Rigel announces Q3 loss of $0.14 per share
Wednesday, 8 Nov 2017 

Nov 7 (Reuters) - Rigel Pharmaceuticals Inc :Rigel announces third quarter 2017 financial results and provides company update.Q3 loss per share $0.14.  Full Article

Rigel announces pricing of public offering of common stock
Thursday, 5 Oct 2017 

Oct 4 (Reuters) - Rigel Pharmaceuticals Inc :Rigel announces pricing of public offering of common stock.Says public offering of 18.1 million common shares priced at $3.35 per share.  Full Article

Rigel Pharmaceuticals q2 loss per share $0.15
Wednesday, 3 Aug 2016 

Rigel Pharmaceuticals Inc : Q2 loss per share $0.15 . Expects cash, cash equivalents and short-term investments as Of June 30 to be sufficient to fund operations into q3 of 2017 . Rigel pharmaceuticals inc qtrly revenues $13.6 million versus $7.4 million .Q2 earnings per share view $-0.20 -- Thomson Reuters I/B/E/S.  Full Article

Rigel Pharmaceuticals Inc initiates Phase 2 clinical trial of fostamatinib in autoimmune hemolytic anemia
Thursday, 25 Feb 2016 

Rigel Pharmaceuticals Inc:Initiates Phase 2 clinical trial of fostamatinib in autoimmune hemolytic anemia.Rigel expects to have results of the Stage 1 segment of the trial by year-end 2016.  Full Article

BRIEF-Rigel announces Q3 loss of $0.14 per share

* Rigel announces third quarter 2017 financial results and provides company update